News Wire

Treatment with ustekinumab (Stelara, Janssen) induced clinical response and clinical remission in adult patients with moderate-to-severe Crohn's disease who had previously failed or were intolerant to treatment with one or more anti-tumor necrosis factor (TNF)-alpha therapies, according to phase 3 data…
A new study demonstrates that mindfulness meditation works on a different pain pathway in the brain than opioid pain relievers. The researchers noted that because opioid and nonopioid mechanisms of pain relief interact synergistically, the results of this study suggest that combining mindfulness-based…
Key factors that can combine to produce a Zika virus outbreak are expected to be present in a number of U.S. cities during peak summer months, new research shows. The Aedes aegypti mosquito, which is spreading the virus in much of Latin America and the Caribbean, will likely be increasingly abundant…
Amid disappointing sales, Takeda Pharmaceuticals U.S.A. has cancelled its collaboration agreement with Orexigen Therapeutics for the commercialization of Contrave (naltrexone/bupropion), an obesity treatment. Takeda announced that it would refocus its resources on drug launches in the antidepressant…
One in four seniors is bringing along stowaways from the hospital to their next stop: so-called “superbugs” on their hands. Moreover, seniors who go to a nursing home or another post-acute care facility will continue to acquire new superbugs during their stay, according to findings made by researchers…
The FDA has approved Kovaltry, Bayer AG’s therapy for the most common form of hemophilia, approximately three weeks after it was cleared for use in Europe. Kovaltry (antihemophilic factor [recombinant]), a prophylactic infusion administered two or three times a week, is indicated for use in adults…
Senator Orrin Hatch (R–Utah), chairman of the Senate Finance Committee, has asked 20 hospital systems to provide detailed records about the controversial practice of allowing surgeons to operate on more than one patient at a time, according to an article in the Boston Globe. Hatch has requested the…
As rising drug prices intensify cost pressures, hospital pharmacies are striving to improve care and expand services without breaking the bank, according to an article in Hospitals & Health Networks. For example, the current interest in ensuring care continuity has prompted many hospitals to involve…
With the expiration in January of the patent on imatinib (Gleevec, Novartis)—the drug that 15 years ago changed chronic myeloid leukemia (CML) from a death sentence to a treatable illness—patients and insurance companies have the opportunity to realize huge cost savings, new research from the Johns…
A virus similar to the one responsible for severe acute respiratory syndrome (SARS) has been found in Chinese horseshoe bats and may be poised to infect humans without the need for adaptation, potentially setting the stage for a widespread outbreak, according to a study from the University of North…
The Centers for Disease Control and Prevention (CDC) has released new recommendations for prescribing opioid medications for chronic pain. The new guideline is for primary care providers—who account for nearly half of all opioid prescriptions—treating adult patients for chronic pain in outpatient…
CMS last year launched the Chronic Care Management (CCM) program in an effort to encourage physicians to focus on value over volume when treating certain Medicare beneficiaries. Managed Care reported at the time that under the program, physicians “can claim a monthly, non–visit-based payment…
Hospitals across the U.S. are finding creative ways to anticipate and mitigate drug-cost pressures, according to an article in the Washington Post. When doctors at the University Hospitals of Cleveland sign in online to prescribe medications, for example, they see an immediately recognizable symbol…
The FDA has accepted the biologics license application (BLA) for atezolizumab (Roche/Genentech) and has granted priority review for the treatment of patients with locally advanced or metastatic urothelial carcinoma who had disease progression during or after platinum-based chemotherapy in the metastatic…
Currently, there is only one class of antiviral drugs against herpesviruses––a family of viruses that causes mononucleosis, herpes, shingles, and meningitis, among other illnesses––meaning that options for treating these infections are limited. If viruses become resistant to these frontline…

Pages